Business Wire

FOURKITES

16.6.2022 10:25:04 CEST | Business Wire | Press release

Share
FourKites Continues Unprecedented Momentum in Europe, Seeing 148% Year-Over-Year Growth

Leading real-time supply chain visibility platform FourKites® today announces it has outpaced its annual growth targets in the European, Middle Eastern and African (EMEA) markets. The company achieved 148% growth in shipments over the last 12 months, exceeding its target projections of 100% growth. The number of customers tracking loads with FourKites in EMEA has grown by 59% in the last 12 months, while the number of carriers tracking shipments has grown by 55% in the same period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220616005418/en/

“Over the last year, we’ve invested heavily in Europe — in our team, our partners, our products and our customers. Today’s complex supply chains require global, end-to-end visibility, and the region is vital to global trade,” says FourKites CEO and founder, Mathew Elenjickal. “We’re seeing that investment reflected by our accelerated growth metrics over the last year.”

Some of FourKites’ most recent customer additions include Barilla Group, Beyond Meat, Cardinal Health, Haworth, LyondellBasell, McCain Foods, Roehm, Rove Concepts and Yamaha Motors.

Local investment pays off

In January 2022, FourKites acquired German supply chain visibility provider NIC-place , the market leader in supply chain visibility software solutions specifically designed for transport companies, carriers and logistics service providers. The acquisition created the largest multimodal carrier network in Europe, serving global shippers with the most comprehensive end-to-end global supply chain visibility platform.

In addition, over the last few months, FourKites has been investing in its local teams with seasoned industry veterans to build the infrastructure needed to support its growing European network. Recent senior-level hires include Katja van Trigt, Senior Director Talent & Development EMEA, who comes to FourKites with an enviable record having worked at American Express, Bausch & Lomb and Infoblox.

Jeroen Peijnenburg, Enterprise Account Director, Southern Europe, will lead FourKites’ supply chain visibility operations across the region. He has worked for many years in leadership positions within global, asset-owning carriers and logistics service providers.

Nicu Ciontea, Carrier Manager, based in Amsterdam, will increase carrier support across Europe. Until recently, Nicu led the carrier sales team at CH Robinson in Amsterdam.

Nicholas Mellings, Enterprise Account Director EMEA will lead FourKites’ UK Sales team. Nicholas brings with him 30 years of experience in the transport and logistics industry, the last five of which were spent working for Transporeon.

New offices

FourKites has also been growing its European presence with new offices. The company has opened a larger European headquarters in Amsterdam; a new office in Munich serving the pivotal German market; and an increased presence in Poland to serve the Eastern European carrier market.

“To support our growing network of European shippers and carriers, we have taken the steps necessary to ensure that we have a strong local presence, with highly specialised knowledge of the European market,” says Elenjickal. Elenjickal himself is currently touring in Europe, visiting the new offices, meeting face to face with customers, and personally welcoming FourKites’ new supply chain experts brought onboard to fuel organic growth.

“Europe is rapidly seizing the benefits of supply chain visibility,” he adds. “European businesses are finding that FourKites’ approach is a natural fit with their current needs, and that synergy is what’s creating more transparency, collaboration and resilience in global supply chains.”

“Digitisation is an important step in Dow’s journey toward the implementation of an end-to-end supply chain visibility strategy,” says Kevin Nielen, Logistics Leader, Dow Chemical. “Our strategic partnership with FourKites enables us to digitise and move away from a manual way of working to an integrated technology platform workflow.”

FourKites Europe in numbers

Top five countries by load volume: Belgium, France, Germany, Netherlands and Italy.

148% growth in EMEA shipments over the last 12 months

59% growth in the number of customers tracking loads in EMEA over the last 12 months

55% growth in the number of carriers tracking shipments in EMEA over the last 12 months

2.4 billion km tracked in EMEA in the last 12 months

Ports: Over the last 12 months, FourKites saw a 15% growth in the number of ports tracked in EMEA. We now cover 295 ports in the region.

Over the last 12 months, FourKites saw a 92% growth in the number of facilities tracked in EMEA. We now cover 134,000 facilities in the region.

About FourKites

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye